Stocks / FATE
Stock profile · 銘柄

Fate Therapeutics, Inc. - Common Stock (FATE)

Fate Therapeutics, Inc. - Common Stock (FATE) last closed at $3.02 (as of 2026-07-01). On Shishin's four-engine momentum model it scored 73/100, flagged by the Suzaku engine (Setting up) on its most recent scan appearance (2026-07-01). It has surfaced in 1 daily scan since 2026-07-01. The figures below are research data, the composite score and the momentum, trend, and volatility indicators the engines observe, not investment advice.

Price updates daily; the engine read reflects FATE's most recent scan appearance. Shishin's live daily signals are published each morning on the rankings board.

Composite score73
Active engineSuzaku
SetupSetting up
Current close$3.02
SectorBiotechnology
Price · last ~60 sessions
$2.703/64/177/1
Indicators · as of 2026-07-01
ADR · 20d11.9%
ATR · 149.3%
RSI · 1466
Return · 30d+54%
Return · 60d+121%
Above MA2028%
Above MA5036%
Range · 20d53%
MA stack3
From 52w high-6%
$ Vol · 30d$11M
Vol ratio1.96×
Frequently asked

What is FATE's Shishin momentum score?

As of 2026-07-01, FATE scores 73/100 on Shishin's four-engine composite, flagged by the Suzaku engine. The score blends momentum, trend, and volatility indicators on a 0 to 100 scale.

Is FATE showing a momentum setup?

FATE's current setup state is "Setting up." This describes what the engines observe in the chart structure, it is a data classification, not a recommendation to buy or sell.

Which Shishin engine flags FATE?

Most recently the Suzaku engine. Each of the four guardians is tuned for a different market regime.

How often has FATE appeared in Shishin scans?

FATE has appeared in 1 daily scan since 2026-07-01. Recurring appearances indicate a persistent setup; one-off appearances are more transient.

How is the Shishin score calculated?

The composite is a weighted blend of momentum (multi-horizon returns), trend (moving-average stack, distance from MAs), and volatility/liquidity (ADR, ATR, dollar volume) indicators, scored per the engine active for the current market regime.

Related reading

Research data, not investment advice. Shishin publishes what its systematic engines observe; it does not recommend buying or selling any security, and is not a registered investment adviser or broker-dealer. See our risk disclosure.

Today's full rankings →5-year track record →More Biotechnology momentum stocks →More Suzaku setups →All covered stocks →